Breast Cancer Prevention-Is there a Future for Sulforaphane and Its Analogs?

Dominika Kuran1, Anna Pogorzelska2, Katarzyna Wiktorska2,3

  • 1Department of Pharmacology, National Medicines Institute, 00-725 Warsaw, Poland.

Nutrients
|May 31, 2020
PubMed

Insights

Sulforaphane (SFN), a compound found in Brassicaceae vegetables, shows promise for breast cancer prevention. Research indicates SFN can inhibit cancer development and protect normal cells.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Breast cancer is a leading global cancer in women.
  • Chemoprevention, including dietary factors, is crucial for prevention and recurrence.
  • Sulforaphane (SFN) from Brassicaceae vegetables is a key chemopreventive agent.

Purpose of the Study:

  • To review the potential of Sulforaphane (SFN) in breast cancer chemoprevention.
  • To analyze SFN's impact on molecular pathways in breast cancer and normal cells.
  • To discuss SFN's role in preventing disease development, recurrence, and metastasis.

Main Methods:

  • Comprehensive literature review of in vitro and in vivo studies.
  • Analysis of SFN's effects on molecular signaling pathways.
  • Evaluation of SFN's protective effects on normal cells against cytostatics.

Main Results:

  • SFN demonstrates potential in preventing breast cancer development and recurrence.
  • SFN may inhibit metastasis and protect normal cells from chemotherapy toxicity.
  • Studies highlight SFN's broad molecular targets in cancer prevention.

Conclusions:

  • SFN is a promising candidate for breast cancer chemoprevention.
  • SFN warrants further investigation for therapeutic and preventive applications.
  • Development of SFN analogs may enhance its clinical utility.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
578
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K